Dr. Sung Lee Lee, MD

Claim this profile

Hematology Oncology Associates of Rockland, P.C.

Studies Follicular Lymphoma
Studies Non-Hodgkin's Lymphoma
1 reported clinical trial
3 drugs studied

Area of expertise

1Follicular Lymphoma
Sung Lee Lee, MD has run 1 trial for Follicular Lymphoma. Some of their research focus areas include:
EZH2 positive
CNG positive
CNG negative
2Non-Hodgkin's Lymphoma
Sung Lee Lee, MD has run 1 trial for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
EZH2 positive
CNG positive
CNG negative

Affiliated Hospitals

Image of trial facility.
Hematology- Oncology Associates Of Rockland, PC

Clinical Trials Sung Lee Lee, MD is currently running

Image of trial facility.

Tazemetostat + Lenalidomide + Rituximab

for Follicular Lymphoma

The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria

More about Sung Lee Lee, MD

Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Sung Lee Lee, MD has experience with
  • Lenalidomide
  • Rituximab
  • Tazemetostat
Breakdown of trials Sung Lee Lee, MD has run
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma

Other Doctors you might be interested in

Sung Ho LeeHematology Oncology Associates of Rockland, P.C.

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sung Lee Lee, MD specialize in?
Sung Lee Lee, MD focuses on Follicular Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Follicular Lymphoma has involved EZH2 positive patients, or patients who are CNG positive.
Is Sung Lee Lee, MD currently recruiting for clinical trials?
Yes, Sung Lee Lee, MD is currently recruiting for 1 clinical trial in Nyack New York. If you're interested in participating, you should apply.
Are there any treatments that Sung Lee Lee, MD has studied deeply?
Yes, Sung Lee Lee, MD has studied treatments such as Lenalidomide, Rituximab, Tazemetostat.
What is the best way to schedule an appointment with Sung Lee Lee, MD?
Apply for one of the trials that Sung Lee Lee, MD is conducting.
What is the office address of Sung Lee Lee, MD?
The office of Sung Lee Lee, MD is located at: Hematology Oncology Associates of Rockland, P.C., Nyack, New York 10960 United States. This is the address for their practice at the Hematology Oncology Associates of Rockland, P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top